• National HealthCare Corporation reported past fourth-quarter 2025 results with revenue of US$386.51 million and net income of US$24.85 million, and full-year 2025 revenue of US$1.52 billion with net income of US$120.02 million.

• The sharp year-over-year increase in quarterly earnings per share from continuing operations, from US$0.39 basic to US$1.60, underscores meaningful efficiency and profitability gains.

• Next, we’ll examine how this earnings-driven improvement in profitability shapes National HealthCare Corporation’s investment narrative for investors.

We’ve uncovered the 14 dividend fortresses yielding 5%+ that don’t just survive market storms, but thrive in them.

For someone looking at National HealthCare Corporation, the core belief is that a relatively conservative, cash‑generating healthcare operator can still offer solid, fundamentals‑driven returns. The latest quarterly and full‑year numbers reinforce that story: higher revenue and a sharp jump in earnings per share suggest the business is squeezing more profit out of its facilities. With the stock recently touching a 52‑week high, this earnings surprise may already be influencing near term sentiment, but it also strengthens key short term catalysts such as confidence in the dividend track record and management’s capital allocation. At the same time, the strong share price performance raises the risk that expectations get ahead of what the business can sustainably deliver, especially without clear forward guidance or analyst coverage to anchor market views.

However, investors should also consider how quickly sentiment could reverse if profitability normalises. National HealthCare’s shares have been on the rise but are still potentially undervalued. Find out how large the opportunity might be.

Three Simply Wall St Community fair value views span roughly US$120 to about US$480 per share, underscoring how far opinions can diverge. Set against NHC’s recent earnings surge and strong price gains, this spread invites you to weigh both optimism and the risk that current enthusiasm fades.

Explore 3 other fair value estimates on National HealthCare – why the stock might be worth over 2x more than the current price!

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your National HealthCare research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.

• Our free National HealthCare research report provides a comprehensive fundamental analysis summarized in a single visual – the Snowflake – making it easy to evaluate National HealthCare’s overall financial health at a glance.